Memories.ai | $8,000,000 | (Jul 25, 2025)
Lyra (YC X25) | $6,000,000 | (Jul 25, 2025)
Maro | $4,300,000 | (Jul 25, 2025)
Certified by Founder
Lodge
Deverra Therapeutics
start up
United States
- Seattle
- 20/09/2023
- Unknown
- $2,400,000
Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.
- Industry Biotechnology
- Website https://www.deverratx.com/
- LinkedIn https://www.linkedin.com/company/deverra-therapeutics/about/
STELLARIA 🌀 | $23,000,000 | (Jul 25, 2025)
LegalOn Technologies | $50,000,000 | (Jul 25, 2025)
Bloom | $1,600,000 | (Jul 25, 2025)
Baxter Aerospace | $6,000,000 | (Jul 25, 2025)
Flend | $3,000,000 | (Jul 25, 2025)
Cascade Space | $5,900,000 | (Jul 25, 2025)
Scopio Labs | $10,000,000 | (Jul 25, 2025)
ArcSpan | $5,200,000 | (Jul 24, 2025)
Dispatch Bio | Undisclosed Amount | (Jul 24, 2025)